Skip to content

How High Temperatures Affect Pregnant Women, Unborn Babies, and Breastmilk production and makeup in India

Effects of extreme heat on maternal, placental and fetal physiology, lactation and newborn health in India - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078527
Enrollment
600
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Wellcome Trust, United Kingdom
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Singleton pregnancies 2. 11-14 weeks’ gestation (as confirmed by ultrasound scan) during the recruitment windows: a. For the GCH site: Warmest months- (April-July) and coolest months (November- February); b.For Pondicherry- warmest month- March-June and coolest- November-February) c.For Chhattisgarh Site: March-June warmest months; November- February coolest months; Risk of high heat exposure based on their occupation and household exposure. 3.Provides consent to all the home/work-based assessments and study assessments throughout pregnancy

Exclusion criteria

Exclusion criteria: 1.Regular access to fixed air conditioning in their home or regular place of work (excluding fans and coolers) 2.An underlying severe medical condition (e.g. end-stage renal failure, cardiac disease, cancer, severe mental health problems, severe anaemia, severe endocrine and metabolic disorders) 3.Plan to move away from the study location before the end of their pregnancy 4.Active vaginal bleeding at the time of recruitment 5.Suspicion of chromosomal abnormalities at first trimester scan

Design outcomes

Primary

MeasureTime frame
Physiological outcomes: 1. Maternal Haemodynamics 2. Foetal and placental assessments via ultrasound and cardiotocography 3. Placental circulating biomarkers 4. Lactational assessment- composition, maturation, serum lactation hormones Timepoint: Continuous measurements across pregnancy and early lactation period

Secondary

MeasureTime frame
Adverse Pregnancy outcomes: 1. Pre-term birth 2. Stillbirth 3. Small for Gestational Age 4. Pre-eclampsia 5. Gestational DiabetesTimepoint: End of Pregnancy

Countries

India

Contacts

Public ContactNitya Wadhwa

Translational Health Science and Technology Institute, Faridabad

shinjini.bhatnagar@thsti.res.in9899014416

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026